T raumaTic brain injury is responsible for ~ 500,000 hospital admissions and 17,500 deaths in the US per year and, as it predominantly affects young people, it results in a huge socioeconomic burden. 30 The term TBI describes a heterogeneous set of injury mechanisms and pathological conditions, but there are common metabolic pathways leading to depressed aerobic metabolism, reduced cellular ATP production, inability to maintain ionic homeostasis, and ultimately cell death. 1, 37, 46, 47 The exact cause of this cellular energy failure is poorly understood, but both reduced substrate delivery and impaired mitochondrial substrate utilization appear to be implicated.
Hyperoxia has been investigated as a potential treatment strategy for increasing aerobic metabolism after TBI, and HBH in particular has shown beneficial effects in both animals and humans. 9, 34, 35 However, chambers capable of delivering HBH to critically ill patients are expensive, and availability is severely limited. Interest has therefore grown in the use of NBH, which is cheap and simple to administer. Studies investigating the use of NBH in adults after TBI have consistently shown increases in brain tissue O 2 tension and reductions in microdialysis-measured brain tissue lactate concentration, 22, 28, 43 but interpretation of these findings is controversial. Some investigators have concluded that they support a beneficial role for NBH, 43 whereas others suggest that NBH may be detrimental. 22 Cerebral microdialysis is an established technique that allows focal measurement of brain tissue biochemistry and is becoming incorporated into routine multimodality monitoring on the neurointensive care unit. 41 Raised microdialysate lactate concentration is associated with tissue hypoxia and poor outcome after TBI.
14 However, it reflects not only the degree of anaerobic metabolism but also the global glycolytic rate. 41 The LPR is considered a superior marker of anaerobic metabolism and is a measure of cellular redox state. 32, 41 However, clinical TBI studies to date have shown no changes in LPR, and this has contributed to the controversy surrounding interpretation of the resulting data.
Broadband NIRS is a noninvasive technique that measures the attenuation of light by tissue at multiple wavelengths. It exploits the fact that biological tissue is relatively transparent to NIR light between 700 and 900 nm, allowing interrogation of the cerebral cortex by optodes placed on the scalp. 31 Biological tissue is a highly scattering medium, and this complicates the calculation of chromophore concentration. However, if the average pathlength of light through tissue is known, the modified Beer-Lambert law, which assumes constant scattering losses, allows calculation of absolute changes in chromophore concentration. The in vivo use of NIRS was first described by Jöbsis in 1977, 17 and it has been used in animals and humans to measure change in concentrations of HbO 2 , HHb, and oxidized CCO. 18, 25, 38, 40, 42 Cytochrome c oxidase is the terminal electron acceptor of the mitochondrial electron transfer chain. As electrons pass along the electron transfer chain, protons are pumped out of the mitochondrial matrix and into the intermembrane space against their concentration gradient, thus providing the driving force for ATP synthesis. Cytochrome c oxidase therefore plays a crucial role in the dynamics of cellular O 2 utilization and energy production, 33 with the movement of electrons down the mitochondrial respiratory chain (via redox reactions) to O 2 resulting in > 95% of cellular O 2 utilization. Cytochrome c oxidase contains a unique Cu-Cu dimer (termed CuA) that is a strong NIR absorber at 830 nm. If the total concentration of CCO remains constant during a study, changes in the NIRS CCO signal represent changes in the CCO redox state. This reflects the balance between electron donation from cytochrome c and O 2 reduction to water. In animals, broadband NIRS-measured cerebral change in oxidized CCO concentration has been validated as a marker of cellular energy status against MR spectroscopy-measured reduction in nucleoside triphosphate levels. 39 It has also recently been shown to correlate with estimated change in cerebral O 2 delivery during hypoxemia in healthy adults. 42 Animal models have indicated that CCO-mediated oxidative metabolism is decreased after TBI and that this effect may last up to 10 days postinjury. 15 Changes in CCO activity after TBI may therefore have an important effect on the ability of mitochondria to metabolize ATP aerobically, and it is possible to investigate these changes noninvasively by using NIRS.
We hypothesize that NBH will cause oxidation in cerebral cellular and mitochondrial redox state in adult patients in the early period post-TBI.
Methods
This study was approved by the Joint Research Ethics Committee of the National Hospital for Neurology and Neurosurgery and the Institute of Neurology and, as all patients were unconscious at the time of the study, written assent was obtained from their personal representatives. Inclusion criteria were a diagnosis of TBI requiring sedation and ventilation on the neurointensive care unit and age > 16 years. Exclusion criteria were the expectation of death or weaning of sedation within 24 hours of injury, a baseline FiO 2 > 60%, or > 48 hours elapsing between the time of injury and the start of the study.
Eight adult patients with a median age of 42 years (range 20-61 years) were recruited into the study. Patient demographics and details of presenting pathological conditions are shown in Table 1 . The median time between the injury and the start of the study was 25 hours (range 22-47 hours).
Monitored Variables
Multimodality monitoring was instigated as part of routine care. Intracerebral pressure (Microsensor, Codman), brain tissue O 2 tension (Licox PMO, Integra Neurosciences), and cerebral microdialysis (CMA 70 or 71, CMA/Microdialysis) catheters were inserted into the brain interstitium through a triple divergent lumen skull bolt (Technicam, Ltd.). Microdialysis catheters were targeted to the pericontusional white matter following the recommendations of the consensus meeting on microdialysis in neurointensive care. 2 The microdialysis catheters were perfused with CNS Perfusion Fluid (CMA/Microdialysis) at a rate of 0.3 µl/minute. No data were collected in the first 4 hours after catheter placement to avoid insertion artifacts. Catheter position was subsequently confirmed on images. Microdialysate glucose, lactate, and pyruvate concentrations were measured at the bedside using a CMA 600 analyzer (CMA/Microdialysis). The mean blood flow velocity in the basal MCA ipsilateral to the NIRS optodes was measured using 2 MHz transcranial Doppler ultrasonography (Nicolet), as a surrogate of CBF. 44 For the purposes of this study, broadband spectrometer optodes were placed 3.5 cm apart in a black plastic holder and fixed to the upper forehead in the midpupillary line ipsilateral to the invasive cerebral monitoring. Light from a stabilized tungsten halogen light source was filtered with 610-nm long-pass and heat-absorbing filters, and transmitted to the head via a 3.3-mm diameter glass optic fiber bundle. 42 Light incident on the detector optode was focused via an identical fiber bundle onto the 400-µm entrance slit of a 0.27-m spectrograph (270M, Instruments SA) with a 300-g/mm grating. The NIR spectra between 650 and 980 nm were collected on a cooled charge coupled device detector (Wright Instruments) giving a spectral resolution of ~ 5 nm.
Study Protocol
All patients received local protocolized ICP and CPP therapy, based on the Joint Section of Neurotrauma and Critical Care of the American Association of Neurological Surgeons 5 and the European Brain Injury Consortium 21 guidelines. After 30 minutes of baseline data collection, the FiO 2 was increased to 60% for 60 minutes and then to 100% for 60 minutes before being returned to baseline for a further 30 minutes. Cerebral microdialysate specimens were collected and analyzed at intervals of 15 minutes, and ABG and glucose concentrations were measured at intervals of 30 minutes, commencing 15 minutes after the start of the baseline period. There is an inherent delay associated with cerebral microdialysis monitoring which relates to diffusion of metabolites into the extracellullar space and across the catheter membrane and the time taken to collect the microdialysate. Therefore, a final microdialysis sample was collected 75 minutes after the FiO 2 was returned to baseline. A schematic of the study protocol is shown in Fig. 1 .
Data Analysis
All monitored variables were recorded on a personal computer and synchronized. Absolute changes in concentrations of CCO, HbO 2 , and HHb were calculated from changes in light attenuation by using a multiple regression technique termed the UCLn algorithm. 24 Correction factors for the wavelength dependence of the optical pathlength were applied to the chromophore absorption coefficients. The individual optical pathlength was calculated continuously using second differential analysis of the 740-nm water feature of the spectral data. 23, 42 Change in total hemoglobin concentration, which can be converted * ASDH = acute subdural hematoma; EDH = extradural hematoma; GCS = Glasgow coma score; RTA = road traffic accident. † All patients were men. 
Statistical Analysis
Summary data were produced for the 4 phases of the study: baseline, 60%, 100%, and return to baseline (baseline return) FiO 2 . For the initial and final baseline periods 15-minute means for each variable were calculated, centered on the time of ABG sampling within that phase. For the 60% and 100% FiO 2 phases, means of the data between the 2 ABG samples within that phase were calculated ( Fig. 1 ). Where not otherwise stated, results are shown as median and interquartile range. Statistical analysis was carried out using statistical software (version 9.1, SAS Institute), and probability values < 0.05 were considered significant. Group changes were compared with baseline using nonparametric analysis of variance and post hoc pairwise comparisons. Correlations between variables were assessed using Spearman rank correlation analysis with Bonferroni corrected 2-tailed tests of significance.
Results
Monitoring of brain tissue O 2 tension failed in 1 patient due to inadvertent catheter removal. All other monitoring modalities were successfully performed in all patients.
Baseline values for the measured variables are shown in Table 2 , and summary changes from baseline are shown in Fig. 2 . An increase in FiO 2 to 60% and 100% was associated with an increase in PaO 2 of 16.5 kPa (8.2-18.5 kPa) and 43.3 kPa (33.8-45.5 kPa), respectively (p < 0.001), but there was no change in blood flow velocity in the basal MCA or total hemoglobin concentration. There was also no change in ICP or CPP during NBH, but a reduction in CPP from baseline of 2.9 mm Hg (1.5-9.5 mm Hg) during the baseline return phase (p < 0.05) was seen. The brain tissue O 2 tension increased by 2.0 kPa (0.9-2.4 kPa) during the 60% FiO 2 phase and by 7.2 kPa (4.5-9.6 kPa) during the 100% FiO 2 phase (p < 0.0001). Arterial and microdialysate glucose concentrations were unchanged during the study. 
Discussion
This is the first report of combined microdialysis and broadband NIRS monitoring of changes in the cerebral redox state in patients with TBI. Our results demonstrate oxidation in cerebral cellular and mitochondrial redox states during NBH in the first 48 hours postinjury. This finding is consistent with the significant regional ischemia that occurs in the acute phase post-TBI 7 and suggests that the patients in this study were suffering a degree of mitochondrial hypoxia at baseline. The oxidation in cerebral redox state that we observed is likely to be associated with increased aerobic metabolism, and NBH therefore has the potential to increase cell survival after TBI.
There are several mechanisms whereby NBH might improve brain cellular metabolism in patients with severe TBI. An increase in arterial oxygenation will improve O 2 delivery as measured by an increase in brain tissue O 2 tension. However, O 2 delivery is determined by both CaO 2 and CBF. The CaO 2 is determined mainly by hemoglobin saturation and, if hemoglobin is already well saturated, the small contribution from the additional amount of dissolved O 2 during NBH is unlikely to have a significant impact on overall O 2 delivery. Alternatively, NBH might improve CMRO 2 by improving the brain's ability to use the delivered oxygen. This might be because impaired mitochondria require a higher PO 2 to function or alternatively because an increased O 2 tension gradient is required to drive O 2 across edematous tissue to reach the mitochondria. 27 Oxygen tension has both direct and indirect modulatory effects on oxidative metabolism and a variety of pathways may be implicated. Intriguingly, an increasing body of literature has demonstrated the ability of NO, which is implicated in the pathobiology of TBI, to inhibit O 2 binding to CCO, and hence its subsequent reduction, by competing for the O 2 binding site in a reversible manner. 29 Raised cerebral NO levels are present after TBI and might therefore contribute to mitochondrial dysfunction. 47 It is possible that elevated mitochondrial O 2 tension might antagonize the effects of NO and therefore favor the binding of oxygen and its subsequent reduction, but this mechanism remains hypothetical at present. The brain tissue O 2 tension reflects the balance between tissue O 2 delivery and utilization. 1 In agreement with several other investigators we found that brain tissue O 2 tension increased during NBH, indicating increased ce rebral O 2 availability. 26, 28, 45 Changes in hemoglobin difference concentration represents changes in the balance between arterial O 2 delivery and O 2 offloading to tissue in the context of stable CBF and CBV. Given that we observed no changes in blood flow velocity in the basal MCA or total hemoglobin during NBH, it can be assumed that cerebral hemodynamics were stable during the study period. The increase in change in hemoglobin difference concentration during NBH therefore suggests improvement in the balance between O 2 delivery and demand, and this is further supported by the associated increase in brain tissue O 2 tension.
The decrease in microdialysate lactate concentration that we observed is similar in direction and magnitude to that found by other workers and is likely to represent im provement in tissue hypoxia during NBH. 22, 28, 43 Microdialysate LPR is a marker of cellular redox state and reflects the nicotinamide adenine dinucleotide/reduced nicotinamide adenine dinucleotide ratio, and the degree of aerobic metabolism. 37 In contrast to previous studies, we observed a significant reduction in microdialysate LPR during NBH, suggesting an increase in aerobic metabolism. The changes in microdialysate variables that we report are small, and it is not possible to ascertain their clinical significance from these data. Nevertheless this pilot study protocol used a relatively short (2-hour) period of NBH, and similar changes in microdialysate lactate concentration during NBH have been associated with improved outcome after TBI. 43 There was no change in arterial or microdialysate glucose concentrations during the study. However, in contrast to the arterial measurements, there was a trend toward reduced microdialysate glucose concentration during NBH, and this might represent increased cerebral glucose utilization.
We observed an increase in change in oxidized CCO concentration during NBH that returned to baseline by the end of the study. There was a positive correlation between change in oxidized CCO concentration and change in brain tissue O 2 tension and a negative correlation between change in oxidized CCO concentration and change in LPR. These changes in cellular and mitochondrial redox state during NBH indicate an increase in electron transfer from CCO to O 2 , thus favoring increased flux through the mitochondrial electron transfer chain and increased aerobic metabolism. In combination with the change in hemoglobin difference concentration, these data suggest that increased arterial and tissue O 2 delivery is driving an increase in O 2 utilization and ATP production. However, simultaneous measurements of CMRO 2 and ATP concentration are needed to confirm this hypothesis.
The change in oxidized CCO concentration in the human brain has not previously been compared with other markers of cellular redox state. The correlation between noninvasive regional (NIRS) and invasive focal (cerebral microdialysis) measures of changes in cerebral redox state suggest that the NIRS changes that we are recording are related to cellular metabolism. The time course of the microdialysate data appears to differ from that of the brain tissue O 2 tension and NIRS data. This may contribute to the correlation between change in brain tissue O 2 tension and change in LPR failing to reach significance after the Bonferroni correction and influence the strength of the relationship between changes in brain tissue O 2 tension and concentration of oxidized CCO.
Hyperbaric hyperoxia has been shown to improve cerebral metabolism and outcome, but studies of NBH have produced variable results. In a fluid percussion injury model in rats, HBH alleviated injury-induced reduction in mitochondrial redox and increased cerebral O 2 consumption. 9 In a randomized controlled clinical trial, Rockswold et al. 34 found that HBH reduced mortality rates after TBI without increasing the number of patients with favorable outcome. In a further study by the same group, HBH reduced the lactate concentration in the cerebrospinal fluid, and this effect lasted for 6 hours after the end of the treatment period. 35 However, cerebrospinal fluid pyruvate was not measured in this study so LPR could not be calculated. In the clinical situation of TBI, NBH has been more widely investigated. Menzel et al. 28 reported reduced microdialysate lactate levels in patients with TBI who were treated using NBH. In a later study, the same group confirmed reduced microdialysate lactate concentrations but found no significant change in LPR during a 24-hour period of 100% FiO 2 commenced within the first 6 hours postinjury, with patients acting as their own controls. 43 In that study NBH resulted in lower mortality rates than those in historic controls. Magnoni et al. 22 also reported reduced microdialysate lactate and no significant changes in LPR after NBH in patents with TBI, but interestingly they found no change in cerebral arteriovenous O 2 difference. These findings were interpreted by the authors as indicating that there was no change in oxidative glucose metabolism during NBH.
Our study differs from others in several respects. First, we positioned our microdialysis catheters in the more affected cerebral hemisphere and targeted the pericontusional brain tissue, 2 using postprocedural imaging to ensure that the catheter tip was not placed within a contusion itself. In the study by Tolias et al., 43 microdialysis catheters were placed in the least affected hemisphere whereas in the study by Magnoni et al. 22 the catheter positioning is unclear. Oxidative depression after TBI is primarily restricted to the ipsilateral cerebral cortex, 15 and positioning of microdialysis catheters has a critical effect on measurement of metabolite microdialysate concentrations. 12 Secondly, there are differences in the timing of the studies and the duration of NBH treatments. In particular, Magnoni et al. 22 enrolled patients up to 79 hours postinjury and studied them for several subsequent days. The potential for cerebral hypoxia is most likely early after TBI, 3 and there may be a critical time window for NBH treatment. In our patient group all studies commenced < 48 hours postinjury.
If hyperoxia improves mitochondrial function and cerebral aerobic metabolism, CMRO 2 will increase. We did not measure CMRO 2 so we are unable to comment further on this issue in relation to our study. However, in a previous study investigating the impact of HBH (100% oxygen at 1.5 atm) on cerebral metabolism, there was a modest improvement in global CMRO 2 in 15% of patients with reduced CBF prior to treatment. 35 In contrast to findings in HBH, current evidence reporting the effect of NBH on CMRO 2 after TBI is inconclusive. In their study, Magnoni et al. 22 reported a nonsignificant reduction in arteriovenous O 2 content difference during NBH, but interpretation of these findings is difficult because CBF was not measured and venous O 2 content was assessed using jugular bulb venous oximetry, which provides a global measure and may miss important regional effects. Con-versely, animal studies have revealed increased CMRO 2 in response to NBH after TBI. 20 More recently, Diringer et al. 10 examined the direct effect of NBH on cerebral metabolism (assessed using PET) in 5 patients with severe TBI. This study is the first to present data directly measuring CMRO 2 during NBH and, on the face of it, seems to indicate that there is no role for this treatment. However, this study measured global CMRO 2 , and regional changes might have been missed. It is also possible that NBH might improve outcome in severe TBI through mechanisms that are not reflected in a measurable increase in CMRO 2 . 13 Further clinical research is therefore needed in larger numbers of patients to establish whether NBH is of therapeutic value after TBI.
In the normal brain, at least, hyperoxia is generally believed to cause vasoconstriction but we found no changes in blood flow velocity in the basal MCA, CBV, or ICP during NBH in our study. Although there was a statistically significant reduction in CPP during the baseline return phase, we do not believe that this was clinically significant and, in any case, the lowest CPP lay within the range allowed in our management protocols. Simple explanations for the lack of evidence of cerebral vasoconstriction in our study are the placement of the microdialysis and NIRS monitors to target the more injured areas of brain, with our findings being consistent with impaired autoregulation within the regions of interest. Alternatively, the slight increase in PaCO 2 that we recorded, which in isolation would tend to cause vasodilation and increase in ICP, might have counteracted any effects of hyperoxic vasoconstriction. However, the absence of evidence of va soconstriction in our study is also likely to be related to the complex response of the injured brain to NBH. 1 Tolias et al. 43 reported a reduction in ICP during NBH in patients with TBI, but Rockswold et al. 35 found that CBF and ICP were only decreased during NBH in those with elevated baseline CBF and that CBF increased during HBH in patients in whom CBF was reduced or normal prior to treatment. Once again, when interpreting these data, it is important to bear in mind the significant metabolic heterogeneity that exists after TBI.
Microdialysis provides a hyperfocal measurement of brain tissue biochemistry but does not identify metabolic changes in tissue distant from the catheter. Given that the perfusate is not static, there is insufficient time for equilibrium to occur across the membrane, and the concentration of metabolites in the microdialysate therefore only represents a fraction of the true brain tissue concentration. This fraction is termed the relative recovery. Relative recovery has been calculated for the metabolites analyzed in our study and has been shown to be equivalent for the CMA 70 and 71 catheters used in this study. 16 As lactate and pyruvate have similar molecular weights, LPR is not affected by changes in relative recovery, and this is one advantage of this measurement over other microdialysis variables. In common with other investigators we demonstrated a prolonged effect of NBH on microdialysate variables, lasting beyond the period of NBH. There is an inherent delay involved in microdialysis monitoring of cellular redox state and although we applied a timing correction to account for the time taken for perfusate to pass along the catheter tubing, the metabolite concentrations measured represent an average over the time of sampling. A delay may also exist related to the diffusion distance between the cellular and extracellular spaces. However, in our study microdialysate lactate concentration and LPR were not significantly different from baseline values by 75 minutes after the end of the hyperoxygenation period.
Historically, the algorithms used to separate the in vivo CCO and hemoglobin signals have been the source of some controversy. 36 Although CCO is a strong NIR absorber it is present in much lower concentrations in the tissue (~ 5.5 µmol/L measured in the adult rat brain) than those of HbO 2 and HHb. 4 This can result in difficulty in separating the CCO and hemoglobin signals, a phenomenon known as cross-talk. Commercially available NIRS systems use only a small number of wavelengths and this makes cross-talk more likely. The broadband instrumentation that we used in this study uses 120 wavelengths and this approach, in conjunction with the UCLn algorithm, has been shown to produce minimal cross-talk in modeling studies. 24 Furthermore, animal studies using mitochondrial inhibitors have shown that NIRS changes in oxidized CCO concentration measurements are stable during large contemporaneous changes in HbO 2 and HHb concentrations. 8 Data from studies in humans during hypoxemia and severe orthostatic hypotension also suggest that the NIRS measured cerebral changes in oxidized CCO concentration signal changes independently of changes in HbO 2 and HHb concentrations. 40, 42 We continuously measured the optical pathlength during this study and, although there was a small change during the 100% FiO 2 phase of the study, all data were corrected for pathlength changes. The potential clinical application of NIRS measurement of change in oxidized CCO concentration has been identified by studies correlating change in oxidized CCO concentration with postoperative neurological dysfunction in patients undergoing cardiac surgery 18 and during severe reductions in SaO 2 associated with sleep apnea. 25 We have demonstrated oxidation in CCO during NBH and this implies that CCO is not fully oxidized in the early stages after severe TBI. Similarly, oxidation in CCO above the resting state has been shown in healthy animals 38 and humans 42 in the recovery period following hypoxemia. Near-infrared spectroscopy therefore provides the opportunity to make continuous, noninvasive, multisite measurements of changes in regional oxygenation and mitochondrial redox state at the bedside.
Normobaric hyperoxia has potentially toxic effects on the lungs, eyes, and central nervous system, and although the doses and duration of treatment required to produce these effects are not clearly defined and are likely to vary between individuals, O 2 toxicity is unlikely to occur when breathing 100% FiO 2 for < 24 hours. 1 There is evidence to suggest increased free radical production when breathing air at high pressure (3 atm) but none showing increased free radical levels at ≤ 1.5 atm.
9 Although hyperoxygenation has the theoretical capacity to increase free radical production, it is also possible that by promoting electron flux through the electron transfer chain, it might prevent the formation of free radicals produced by buildup of reducing equivalents. Oxygen toxicity is extremely unlikely following the regimen applied during this study, but further work is required to investigate the risks of longer periods of NBH after TBI.
This pilot study has several limitations. We studied only a small number of patients with TBI, and further data collection in a large cohort of patients is required to validate these findings. The blood flow velocity in the basal MCA is a surrogate marker of CBF and relies on there being no significant changes in MCA caliber during the study. Continuous bedside measurement of absolute CBF, in conjunction with measurements of arterial and venous O 2 content difference and calculation of CMRO 2 , would aid further investigation of NBH. In this study patients acted as their own controls, and it is possible that the changes that we observed might have been influenced by the natural course of TBI. However, we do not believe this is the case as all measured variables returned toward, or reached, baseline values by the end of the study. Furthermore, changes in cerebral metabolism unrelated to our interventions are likely to have been minimal as systemic variables were stable over the time course of this study. The significant disease heterogeneity that exists within the diagnosis of TBI makes it extremely difficult, if not impossible, to identify control cohorts adequately matched for disease type and severity within a data set of the size that we present. There was a relatively high mortality rate in our study population and we believe that this is likely to be related to our selection of patients for cerebral microdialysis monitoring. In our center, patients in whom sedation is stopped shortly after admission following either conservative or surgical management are not monitored using cerebral microdialysis, and patients included in this study therefore represent the more severely injured end of the spectrum of our TBI admissions.
Conclusions
We have demonstrated oxidation in cerebral cellular and mitochondrial compartments during NBH in patients with TBI using 2 independent monitoring techniques. Cerebral microdialysis and NIRS monitoring provide complementary information, which can further our understanding of TBI pathophysiology. It might also be possible to use these techniques to guide targeted treatment strategies. Our results suggest that NBH has the potential to improve outcome after TBI and that further investigation is warranted.
